Skip to main content

Find Clinical Trials

Home
Conditions
Breast Diseases

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,433 public trials 2,002 recruiting studies

Refine in advanced search Browse all conditions

Breast Diseases trial results

Completed

Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis

NCT03483012

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients

NCT01027416

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: University of Chicago Chicago, Illinois, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer

NCT04732598

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Cancer Institute Hospital of JFCR Tokyo, Japan

View Trial Details

Completed

Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact

NCT05376527

Conditions: Breast Diseases, Breast Neoplasms, DNA Virus Infections, +9 more
Locations: N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation Moscow, Russia

National Medical Research Radiological Centre (NMRRC) of the Ministry of Health of the Russian Federation Obninsk, Russia

N.N. Petrov National Medical Research Center of Oncology Saint Petersburg, Russia

Oncology Research Center, LLC Saint Petersburg, Russia

View Trial Details

Completed

Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan

NCT05153187

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Pfizer Japan Tokyo, Japan

View Trial Details

Completed

Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

NCT02695121

Conditions: Bladder Cancer, Breast Cancer, Breast Diseases, +14 more
Locations: Research Site Wilmington, Delaware, United States

Research Site Washington D.C., District of Columbia, United States

Research Site Utrecht, Netherlands

Research Site London, United Kingdom

View Trial Details

Completed

Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival

NCT01574170

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer Starting a Third Line Chemotherapy, +4 more
Locations: C.M.C.O. Claude Bernard Albi, France

Institut de Cancérologie de l'Ouest Paul Papin Angers, France

CHU Jean Minjoz Besançon, France

CHRU Brest Brest, France

View all 16 locations

View Trial Details

Completed

SENOVIE France - Therapeutic Mobility and Breast Cancer

NCT06503393

Conditions: Breast Cancer Female, Breast Diseases, Breast Neoplasms, +4 more
Locations: Robert Ballanger Hospital Aulnay-Sous-Bois Aulnay-sous-Bois, France

Avicenne University Hospital AP-HP Bobigny, France

Saint-Louis University Hospital AP-HP Paris, France

Delafontaine Hospital Saint-Denis Saint-Denis, France

View Trial Details

Completed

Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening

NCT03495115

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

NCT04085276

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: The Fifth Medical Center of PLA General Hospital Beijing, Beijing Municipality, China

Beijing Hospital Beijing, Beijing Municipality, China

Chinese PLA General Hospital Beijing, Beijing Municipality, China

Peking University Shougang Hospital Beijing, Beijing Municipality, China

View all 55 locations

View Trial Details